Sources

7 Total Sources

FDA Grants Trutakna Accelerated Approval for IgA Nephropathy After 42% Proteinuria Cut

Center67%

Right33%

Monthly Prescribing Reference6h ago

FDA Grants Accelerated Approval to Trutakna for Primary IgA Nephropathy to Reduce Proteinuria

StockTitan6h ago

Vera Therapeutics Wins FDA Approval for TRUTAKNA | VERA Stock News

The Globe and Mail6h ago

Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy - The Globe and Mail

Marketscreener.com6h ago

Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy | MarketScreener

MD Magazine6h ago

FDA Approves Atacicept (Trutakna) for IgA Nephropathy | HCPLive

Investing.com Canada6h ago

FDA approves Vera's Trutakna for IgA nephropathy treatment By Investing.com

Endpoints News6h ago

Vera's IgAN approval kicks off competition with Otsuka